Related references
Note: Only part of the references are listed.Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes
E. Keen-Rhinehart et al.
MOLECULAR PSYCHIATRY (2009)
A common genetic predisposition to stress sensitivity and stress-induced nicotine craving
Andras Bilkei-Gorzo et al.
BIOLOGICAL PSYCHIATRY (2008)
CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF
Lucianne Groenink et al.
BIOLOGICAL PSYCHIATRY (2008)
Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior
A. Lu et al.
MOLECULAR PSYCHIATRY (2008)
The molecular neurobiology of depression
Vaishnav Krishnan et al.
NATURE (2008)
Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and β-arrestin-2 recruitment:: a mechanism regulating stress and anxiety responses
Robert H. Oakley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Stress sensitivity and the development of affective disorders
Tracy L. Bale
HORMONES AND BEHAVIOR (2006)
Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats
Sung-Jin Kim et al.
NEUROPHARMACOLOGY (2006)
Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior
Alon Chen et al.
JOURNAL OF NEUROSCIENCE (2006)
Corticotropin-releasing factor (CRF), but not corticosterone, increases basolateral amygdala CRF-binding protein
RJ Herringa et al.
BRAIN RESEARCH (2006)
Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain
A Korosi et al.
BRAIN RESEARCH (2006)
Sensitivity to stress: Dysregulation of CRF pathways and disease development
TL Bale
HORMONES AND BEHAVIOR (2005)
Stress and the brain:: From adaptation to disease
ER de Kloet et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Glucocorticoids, depression, and mood disorders: structural remodeling in the brain
BS McEwen
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated
SJ Perry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The therapeutic potential of CRF1 antagonists for anxiety
EP Zorrilla et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
The effects of acute stress on the regulation of central and basolateral amygdala CRF-binding protein gene expression
RJ Herringa et al.
MOLECULAR BRAIN RESEARCH (2004)
Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of β-arrestin 1 recruitment
TN Rasmussen et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Corticotropin-releasing factor in brain: A role in activation, arousal, and affect regulation
SC Heinrichs et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress
MB Müller et al.
NATURE NEUROSCIENCE (2003)
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
A Holmes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations
A Dirks et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation
B Roozendaal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain
KL Brunson et al.
EXPERIMENTAL NEUROLOGY (2002)
HPA axis dysregulation in mice overexpressing corticotropin releasing hormone
L Groenink et al.
BIOLOGICAL PSYCHIATRY (2002)
Hypophysiotropic neurons of the paraventricular nucleus respond in spatially, temporally, and phenotypically differentiated manners to acute vs. repeated restraint stress
V Viau et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor1 receptor antagonist.: II.: Characterization in rodent models of stress-related disorders
G Griebel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression
JMHM Reul et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Topography of projections from amygdala to bed nuclei of the stria terminalis
HW Dong et al.
BRAIN RESEARCH REVIEWS (2001)
Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats
SC Stout et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)